주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
2,298 )
기사목록 보기 형태
제목형
요약형
포토형
GC Pharma’s Neulapeg proves effective in recurrent/refractory multiple myeloma study
Marianne Chang
2022.11.28 15:13
Will Zejula’s indication for 4th or more ovarian cancer treatments be deleted in Korea, too?
Kim Yun-mi
2022.11.28 13:42
Inventage Lab’s multiple sclerosis drug candidate to get orphan drug status
Marianne Chang
2022.11.28 11:54
Hanmi’s US partner gives up poziotinib, shifts focus to Rolvedon
Marianne Chang
2022.11.28 10:37
Daewoong holds workshop on Fexuclue for Korean, Philippine doctors
Park Gi-taek
2022.11.25 16:49
Neurocritical care group eyes ‘big picture’ for next 10 years
Kim Eun-young
2022.11.25 15:45
JW Pharmaceutical OKed for phase 3 multi-country gout drug trial
Choi Hye-won
2022.11.25 14:59
Qiagen Korea scores local permit for companion diagnostic of Janssen’s Balversa
Marianne Chang
2022.11.25 14:20
Janssen's urinary tract epithelial cancer drug ‘Balversa’ gets regulatory nod
Kim Chan-hyuk
2022.11.25 11:37
FDA hands Hanmi’s US partner, Spectrum, a poziotinib CRL to request supplementary data
Marianne Chang
2022.11.25 11:34
‘Ibuprofen and naproxen don't relieve osteoarthritis. So, reconsider their prescription.’
Jeong Min-jun
2022.11.24 15:59
Crystal Genomics becomes largest shareholder of Pangen Biotech
Lee Han-soo
2022.11.24 15:14
처음
이전
이전
이전
101
102
103
104
105
106
107
108
109
110
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기